NVS
Novartis AG ADR
NYSE: NVS · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$147.85
+3.44% today
Updated 2026-04-30
Market cap
$282.11B
P/E ratio
21.18
P/S ratio
4.99x
EPS (TTM)
$6.98
Dividend yield
3.21%
52W range
$102 – $165
Volume
2.1M
Novartis AG ADR (NVS) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $68.01B | $75.45B | $78.30B | $95.50B | $123.32B | $117.50B | $124.22B | $126.25B | $125.39B | $131.56B | $130.12B | $133.08B | $145.56B | $118.41B | $132.19B | $131.79B | $117.45B | $99.94B | $102.25B | $115.57B |
| Cash & equivalents | $3.81B | $5.36B | $2.04B | $2.89B | $5.32B | $3.71B | $5.55B | $6.69B | $13.02B | $4.67B | $7.01B | $8.86B | $13.27B | $11.11B | $9.66B | $12.41B | $7.52B | $13.39B | $11.46B | $11.44B |
| Current assets | $21.40B | $27.43B | $20.88B | $33.69B | $26.68B | $24.08B | $28.00B | $30.54B | $37.56B | $22.84B | $24.93B | $28.21B | $35.56B | $29.50B | $29.67B | $45.72B | $36.91B | $30.48B | $29.70B | $30.46B |
| Total liabilities | $26.71B | $26.06B | $27.86B | $38.04B | $53.55B | $51.56B | $55.00B | $51.78B | $54.54B | $54.43B | $55.23B | $58.85B | $66.87B | $62.86B | $75.52B | $63.97B | $58.03B | $53.20B | $58.12B | $69.02B |
| Current liabilities | $16.23B | $16.64B | $16.50B | $19.47B | $24.66B | $23.15B | $24.05B | $26.37B | $26.97B | $23.71B | $22.21B | $23.40B | $29.61B | $28.26B | $33.06B | $30.21B | $28.66B | $26.39B | $28.69B | $27.28B |
| Long-term debt | $656.00M | $677.00M | $2.18B | $8.68B | $14.36B | $13.86B | $13.78B | $11.24B | $13.80B | $16.33B | $17.90B | $23.22B | $22.47B | $20.35B | $26.26B | $22.90B | $20.24B | $18.44B | $21.37B | $27.93B |
| Shareholder equity | $41.11B | $49.22B | $50.29B | $57.39B | $63.20B | $65.84B | $69.09B | $74.34B | $70.77B | $77.05B | $74.83B | $74.17B | $78.61B | $55.47B | $56.60B | $67.66B | $59.34B | $46.67B | $44.05B | $46.13B |
| Retained earnings | $40.26B | $48.41B | $49.83B | $56.56B | $62.36B | $64.95B | $70.22B | $73.06B | $72.43B | $80.38B | $81.15B | $77.64B | $82.19B | $59.27B | $57.16B | $70.99B | $63.54B | $49.65B | $46.56B | $44.72B |
| Accounts receivable | $7.97B | $8.50B | $8.57B | $10.01B | $11.72B | $12.37B | $12.53B | $12.62B | $10.26B | $10.55B | $10.20B | $10.07B | $9.68B | $9.17B | $9.07B | $9.62B | $9.89B | $9.38B | $8.21B | $10.93B |
| Inventory | $4.50B | $5.46B | $5.79B | $5.83B | $6.09B | $5.93B | $6.74B | $7.27B | $6.09B | $6.23B | $6.25B | $6.87B | $6.96B | $5.98B | $7.13B | $6.67B | $7.17B | $5.91B | $5.72B | $6.27B |
| Goodwill | $10.66B | $11.11B | $11.29B | $12.04B | $29.69B | $29.94B | $31.09B | $31.03B | $29.31B | $31.17B | $30.98B | $31.75B | $35.29B | $26.52B | $30.00B | $29.59B | $29.30B | $23.34B | $24.76B | $25.57B |